Cargando…
Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
The introduction of TNFα blockers has revolutionized the treatment of ankylosing spondylitis (AS). The objectives of this review are to summarize the most up-to-date data on long-term efficacy and safety of infliximab in AS, with special emphasis on axial and extra-articular disease, predictors of r...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657809/ https://www.ncbi.nlm.nih.gov/pubmed/26640380 http://dx.doi.org/10.2147/TCRM.S55928 |